Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Top 10 Research Questions Related to Physical Activity and Multiple Sclerosis.
Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source.
The influence of tetracyclines on T cell activation.
Shape Analysis of the Corpus Callosum and Cerebellum in Female MS Patients with Different Clinical Phenotypes.
Multiple sclerosis and vitamin D during pregnancy and lactation.
Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
Transcriptomic meta-analysis of multiple sclerosis and its experimental models.
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
Scoring treatment response in patients with relapsing multiple sclerosis.
Vitamin D and multiple sclerosis: where do we go from here?
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Mitochondrial changes within axons in multiple sclerosis: an update.
France Banned AB Science Drug Studies Because of Side Effects
Vitamin d and multiple sclerosis.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Do cortical lesions help us to distinguish MS from NMO?
Deafness in Patients with Multiple Sclerosis.
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
New management algorithms in multiple sclerosis.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.

Pages